ASPEKT R&D A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.6% 6.4% 6.6% 4.1% 4.3%  
Credit score (0-100)  37 37 35 49 47  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,007 0 0 0 0  
Gross profit  399 2,020 1,342 1,579 1,709  
EBITDA  -793 1,143 199 286 334  
EBIT  -919 985 80.2 194 298  
Pre-tax profit (PTP)  -914.5 976.2 70.5 197.0 307.6  
Net earnings  -721.1 775.5 52.5 151.2 238.1  
Pre-tax profit without non-rec. items  -914 976 70.5 197 308  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  62.1 47.1 32.0 44.1 44.1  
Shareholders equity total  451 1,227 1,279 1,230 1,169  
Interest-bearing liabilities  144 524 541 0.0 0.0  
Balance sheet total (assets)  976 2,718 2,384 1,698 1,731  

Net Debt  -44.9 445 73.0 -936 -801  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,007 0 0 0 0  
Net sales growth  -60.7% -100.0% 0.0% 0.0% 0.0%  
Gross profit  399 2,020 1,342 1,579 1,709  
Gross profit growth  -76.0% 406.0% -33.6% 17.7% 8.3%  
Employees  2 2 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  976 2,718 2,384 1,698 1,731  
Balance sheet change%  -61.0% 178.4% -12.3% -28.8% 1.9%  
Added value  -792.8 1,143.5 199.0 313.2 333.8  
Added value %  -78.8% 0.0% 0.0% 0.0% 0.0%  
Investments  -253 -75 -237 -183 -71  

Net sales trend  -1.0 -2.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  -78.8% 0.0% 0.0% 0.0% 0.0%  
EBIT %  -91.3% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -230.3% 48.7% 6.0% 12.3% 17.4%  
Net Earnings %  -71.6% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  -59.1% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  -90.9% 0.0% 0.0% 0.0% 0.0%  
ROA %  -51.2% 53.7% 3.7% 10.1% 17.9%  
ROI %  -71.8% 79.5% 5.0% 12.9% 24.5%  
ROE %  -88.8% 92.4% 4.2% 12.0% 19.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  46.2% 45.1% 53.7% 72.5% 67.5%  
Relative indebtedness %  46.1% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  27.3% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  5.7% 39.0% 36.7% -327.0% -239.9%  
Gearing %  31.9% 42.7% 42.3% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.5% 4.8% 4.3% 3.3% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.5 1.7 2.1 3.8 3.2  
Current Ratio  1.5 1.7 2.1 3.8 3.2  
Cash and cash equivalent  188.8 78.0 468.0 935.6 800.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  50.1 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  17.2 0.0 0.0 0.0 0.0  
Current assets / Net sales %  69.1% 0.0% 0.0% 0.0% 0.0%  
Net working capital  231.3 978.3 1,131.2 1,160.7 1,127.0  
Net working capital %  23.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  503 0 0 0 0  
Added value / employee  -396 572 99 157 167  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -396 572 99 143 167  
EBIT / employee  -460 492 40 97 149  
Net earnings / employee  -361 388 26 76 119